CAS 2134641-34-0

Epcoritamab

CAS : 2134641-34-0

Epcoritamab

Degré de pureté : ≥95%

Ref: 54-BUP20056

Epcoritamab

CAS : 2134641-34-0

Epcoritamab (GEN3013) is a novel subcutaneous CD3xCD20 bispecific T-cell binding antibody for the study of relapsed or refractory large B-cell lymphoma.

Degré de pureté : 97.6% (SDS-PAGE); 97.2% (SEC-HPLC) - 98.9% (SDS-PAGE); 98.8% (SEC-HPLC)

Couleur et forme : Liquid

Ref: TM-T78331

Epcoritamab

CAS : 2134641-34-0

A bispecific monoclonal antibody CD20-directed CD3 T-cell engager.

Ref: 3D-CLA1589